About this trial
Develop an emergency PanorOmics Wide Association Study (ePWAS) for the early, rapid biological and pathophysiological characterisation of known and novel Infectious Diseases in adult patients presenting to emergency departments with suspected, acute, community-acquired respiratory infectious disease (scaRID).
Phase 1
1. Develop an ED-ID biobank (named ePWAS-RID). Phase 2 2. Targeted research for the discovery of novel diagnostics, prognostics and therapeutics
Eligibility criteria
Qualifiers
Adults ≥18 years of age; AND
Suspected, acute, community-acquired, respiratory, infectious disease (scaRID)*; AND
Informed consent.
Community acquired (not hospitalised for <28 days); AND
Disqualifiers
Refusal of consent;
Recent hospitalisation (<28 days);
Enrolled in another clinical trial
Cellulitis;
Trial design
Treatments tested in this trial
- Biomarker blood draw and saliva collection
Treatment groups
7
Treatment groupsSee each treatment group below.